Skip to main content

Kreatech to Use GE Healthcare Dyes in Microarray Kits

This article has been corrected from a previous version that ran yesterday. GE Healthcare is providing the Cy3 and Cy5 dyes under the agreement, not the Universal Linkage System, which was developed by Kreatech. 

NEW YORK, Feb. 22 (GenomeWeb News) - Kreatech Biotechnology said yesterday that it has signed an agreement allowing it to use GE Healthcare's Cy3 and Cy5 dyes in combination with its Universal Linkage System in DNA microarray-labeling kits.

Under the terms of the agreement, Kreatech gains global rights for the use of Cy3 and Cy5 dyes with the Universal Linkage System in fluorescent applications within the life sciences market, Kreatech said. Kreatech will use the technology to develop and manufacture microarray-labeling kits for amplified RNA labeling and genomic DNA labeling, it said.

Kreatech said the technology enables direct DNA labeling, negating the need for modified nucleotides.

Financial terms of the deal were not disclosed.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.